000 | 01347 a2200361 4500 | ||
---|---|---|---|
005 | 20250515170850.0 | ||
264 | 0 | _c20090522 | |
008 | 200905s 0 0 eng d | ||
022 | _a1749-6632 | ||
024 | 7 |
_a10.1111/j.1749-6632.2008.03819.x _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aDschietzig, Thomas | |
245 | 0 | 0 |
_aFirst clinical experience with intravenous recombinant human relaxin in compensated heart failure. _h[electronic resource] |
260 |
_bAnnals of the New York Academy of Sciences _cApr 2009 |
||
300 |
_a387-92 p. _bdigital |
||
500 | _aPublication Type: Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 | _aDrug Administration Schedule |
650 | 0 | 4 |
_aHeart Failure _xdrug therapy |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aInfusions, Intravenous |
650 | 0 | 4 |
_aRecombinant Proteins _xadministration & dosage |
650 | 0 | 4 |
_aRelaxin _xadministration & dosage |
650 | 0 | 4 | _aTreatment Outcome |
700 | 1 | _aTeichman, Sam | |
700 | 1 | _aUnemori, Elaine | |
700 | 1 | _aWood, Susy | |
700 | 1 | _aBoehmer, Julia | |
700 | 1 | _aRichter, Christoph | |
700 | 1 | _aBaumann, Gert | |
700 | 1 | _aStangl, Karl | |
773 | 0 |
_tAnnals of the New York Academy of Sciences _gvol. 1160 _gp. 387-92 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1111/j.1749-6632.2008.03819.x _zAvailable from publisher's website |
999 |
_c18845078 _d18845078 |